NMPA Approval

Olmesartan Medoxomil and Hydrochlorothiazide Tablets

Approval Number

国药准字H20233539

Company上海现代制药股份有限公司

Registration Date

May 12, 2023

Drug Information

Generic Name

奥美沙坦酯氢氯噻嗪片

Dosage Form

片剂

Strength

每片含奥美沙坦酯20mg与氢氯噻嗪12.5mg

Drug Type

化学药品

Registration Date

May 12, 2023

Company Information

Applicant Company

Company Name上海现代制药股份有限公司

Company Address

上海市浦东新区建陆路378号

Manufacturing Company

Company Name

吉林省德商药业股份有限公司;上海现代制药股份有限公司

Company Address

吉林省辉南县经济开发区北一街；上海市浦东新区建陆路378号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯氢氯噻嗪片 - NMPA 批准文号 | MedPath